Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $825.45
-
Support level$809.86
-
Resistance levelN/A
-
Beta0.6
-
RSI (14-day)42.8
- LLY is one of this month's top performers with a return of 13.9 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- LLY is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $625.65 | $929.72 | 70.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $787.44 | $767.50 | $817.29 | $814.80 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week8.3%
-
In the next month18.1%
-
In the next year77.6%
| Period | Value |
|---|---|
| Historical (5 year) | 32.3% |
| Last month | 39.5% |
| Current estimate | 30.6% |
| Next month forecast | 31.9% |